36th Annual Melanoma and Cutaneous Oncology Symposium

36th Annual Melanoma and Cutaneous Oncology Symposium is organized by Scripps Conference Services & CME and will be held from Jan 24 - 25, 2026 at Hyatt Regency Mission Bay Spa and Marina, San Diego, California, United States of America.

Overview:
The field of cutaneous oncology continues to evolve at a rapid pace, with groundbreaking advancements reshaping prognosis, molecular diagnostics, treatment strategies, and patient follow-up. The Melanoma and Cutaneous Oncology Symposium is thoughtfully designed to deliver practical, focused, and up-to-date educational insights aimed at enhancing the care and outcomes of individuals with skin cancers. Through dynamic interactive lectures and real-world patient case discussions, nationally renowned experts will share the latest evidence on prevention, risk stratification, early detection, genetic influences, current therapeutic approaches, and emerging treatments.

This symposium will comprehensively address a wide range of topics, including challenges in surgical management, the role of adjuvant therapies, innovative treatments for advanced disease, and personalized strategies to optimize patient care. By participating, clinicians will gain the knowledge and tools necessary to confidently navigate complex patient scenarios, make informed clinical decisions, and ultimately improve outcomes while preserving patients’ quality of life.

Objectives:
Upon completion of this activity, participants should be able to:

• Explain the epidemiology, underlying pathophysiology, and contributing risk factors for melanoma, squamous cell carcinoma, Merkel cell carcinoma, and other skin-related neoplasms.
• Utilize best practices for the diagnosis, assessment, and classification of melanoma and other cutaneous cancers.
• Recognize genetic mutations and biomarkers critical for diagnosing and assessing the risk in patients with melanoma or squamous cell carcinoma.
• Incorporate cutting-edge medical therapies and surgical approaches into the management of patients with cutaneous malignancies.
• Implement innovative strategies to deliver comprehensive, multidisciplinary care for patients at every stage of their skin cancer journey.